Research Library

In the current campaign for Harris County district attorney, both incumbent D.A. Devon Anderson and challenger Kim Ogg have not only proposed to change the way marijuana use is handled by that office, but have also made the issue a centerpiece of their campaigns. Drug policy fellow Katharine Neill examines each candidate’s proposed changes in a new Baker Institute Blog.

The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.

Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.

Marijuana decriminalization and legalization have gone past being a trend and are settling in as federal policy, writes nonresident fellow Gary Hale, a 31-year veteran of the Drug Enforcement Administration. This policy brief includes recommendations for how the DEA can adjust its policies to adopt a new paradigm on marijuana policy.

Women living with HIV in the Middle East face public scrutiny, stigmatization and even abandonment. It is critical not only to curb the spread of HIV in the region, but also to educate and protect women who may be less knowledgeable about the disease, writes Ariana Marnicio, research analyst for the Women and Human Rights in the Middle East Program.

By Steve Nolin

Following the legalization of retail marijuana sales in Colorado and Washington, and medical marijuana in…

In 2012, the Drug Policy Program at Rice University’s Baker Institute and the South Texas College of Law (STCL) established a unique agreement to work together on model legislation for the decriminalization and regulation of marijuana in Texas. The collaboration was initiated by students and supported by the administrations and faculties of both educational institutions. South Texas College of Law students produced 19 separate statutes for their public law course in the spring 2013 semester. They were asked to write model legislation regarding some aspect of marijuana policy and provide well-reasoned commentary for their statutes. Experts from the Baker Institute’s Drug Policy Program gave guest lectures on drug policy issues and worked with STCL professor Drury Stevenson to provide a general direction for the course. The goal of the collaboration between the STCL and the Baker Institute was to create a variety of statutes that legislators and government officials can consult and learn from as marijuana policy is increasingly debated over the next decade. Neither the Baker Institute nor the South Texas College of Law endorses any particular policy. The model legislation has not undergone editorial review by the Baker Institute.

Many contemporary medical ethicists dismiss the centuries-old Hippocratic Oath as outdated because of the enormous scientific, social, economic, and political changes since Hippocrates' time. Health policy scholar Hagop Kantarjian makes a case for its relevance.